Nicholas J. Porter

Nicholas J. Porter

Auto-generated profile, based on publicly available information

Nicholas J. Porter

California Institute of Technology

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
YHYang Hai
Yang Hai
SSStephen A. Shinsky
Stephen A. Shinsky
NPNicholas J. Porter
Nicholas J. Porter
DCDavid W. Christianson
David W. Christianson
Cationic polyamines such as spermidine and spermine are critical in all forms of life, as they regulate the function of biological macromolecules. Intracellular polyamine metabolism is regulated by reversible acetylation and dysregulated polyamine metabolism is associated with neoplastic diseases such as colon cancer, prostate cancer and neuroblastoma. Here we report that histone deacetylase 10 (HDAC10) is a robust polyamine deacetylase, using recombinant enzymes from Homo sapiens (human) and Danio rerio (zebrafish). The 2.85 Å-resolution crystal structure of zebrafish HDAC10 complexed with a transition-state analogue inhibitor reveals that a glutamate gatekeeper and a sterically constricted active site confer specificity for N8-acetylspermidine hydrolysis and disfavour acetyllysine hydrolysis. Both HDAC10 and spermidine are known to promote cellular survival through autophagy. Accordingly, this work sets a foundation for studying the chemical biology of autophagy through the structure-based design of inhibitors that may also serve as new leads for cancer chemotherapy.

4 December 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NPNicholas J. Porter
Nicholas J. Porter
AMAdaickapillai Mahendran
Adaickapillai Mahendran
RBRonald Breslow
Ronald Breslow
DCDavid W. Christianson
David W. Christianson
Significance: Histone deacetylase 6 (HDAC6) is a zinc metalloenzyme that serves as the tubulin deacetylase in the cell cytosol. Inhibition of tubulin deacetylase activity leads to suppression of microtubule dynamics, causing cell cycle arrest and apoptosis, which is a validated strategy for cancer chemotherapy. Selective inhibition of HDAC6 is clinically preferable, since unwanted inhibition of other HDAC isozymes can lead to undesirable off-target effects. Here, X-ray crystal structures of HDAC6-inhibitor complexes reveal molecular features responsible for the isozyme selectivity measured in inhibition assays, including an unusual monodentate hydroxamate-Zn 2+ coordination mode as well as intermolecular interactions of bulky inhibitor substituents. These observations will inform the design of HDAC6-selective inhibitors with improved properties.

1 December 2019 in Current Opinion in Structural Biology
Verified
Journal Article
Closed access
NPNicholas J Porter
Nicholas J Porter
DCDavid W Christianson
David W Christianson

17 August 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
NPNicholas J. Porter
Nicholas J. Porter
JOJeremy D. Osko
Jeremy D. Osko
DDDaniela Diedrich
Daniela Diedrich
TKThomas Kurz
Thomas Kurz
JHJacob Hooker
Jacob Hooker
DCDavid W. Christianson
David W. Christianson

15 January 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KVKatharina Vögerl
Katharina Vögerl
NONghia Ong
Nghia Ong
JSJohanna Senger
Johanna Senger
DHDaniel Herp
Daniel Herp
KSKarin Schmidtkunz
Karin Schmidtkunz
Franz BracherFranz Bracher
Franz Bracher

13 May 2022 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
NPNicholas J. Porter
Nicholas J. Porter
EDEmma Danelius
Emma Danelius
TGTamir Gonen
Tamir Gonen
FAFrances H. Arnold
Frances H. Arnold